Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma
NCT ID: NCT04270266
Last Updated: 2025-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
71 participants
INTERVENTIONAL
2019-09-06
2026-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life in Younger Leukemia and Lymphoma Survivors
NCT00956475
Integrative Medicine in Lymphoma Survivors
NCT05982223
Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer
NCT03709225
Healthy Exercise for Lymphoma Patients (HELP)
NCT00111865
Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
NCT06409065
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Examine the feasibility of the mind-body intervention in adolescents and young adults (AYAs) with lymphoma.
SECONDARY OBJECTIVE:
I. Establish the initial intervention efficacy regarding psychological distress and cancer symptoms (tertiary objective) relative to an attention control (AC) group.
EXPLORATORY OBJECTIVE:
I. Explore mediation (e.g., mindfulness, compassion, social connection, inflammatory processes) and moderation (e.g., demographic and medical factors) of the intervention effects.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients attend meditation group sessions over 75 minutes once weekly for up to 5 weeks.
GROUP II: Patients attend educational group sessions over 75 minutes once weekly for up to 5 weeks.
After completion of study intervention, patients are followed at 6 and 12 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (meditation)
Patients attend meditation group sessions over 75 minutes once weekly for up to 5 weeks.
Meditation Therapy
Attend meditation sessions
Questionnaire Administration
Ancillary studies
Group II (educational)
Patients attend educational group sessions over 75 minutes once weekly for up to 5 weeks.
Educational Intervention
Attend educational sessions
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational Intervention
Attend educational sessions
Meditation Therapy
Attend meditation sessions
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eastern Cooperative Oncology Group (ECOG) performance status of 2 or below
* Having access to the internet
* Able to read, write and speak English
Exclusion Criteria
* Regular (self-defined) participation in psychotherapy or a formal cancer support group
18 Years
39 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathrin Milbury
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Texas MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2019-05846
Identifier Type: REGISTRY
Identifier Source: secondary_id
2019-0282
Identifier Type: OTHER
Identifier Source: secondary_id
2019-0282
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.